Clozapine resistant schizophrenia: Newer avenues of management

About 40%-70% of the patients with treatment-resistant schizophrenia have a poor response to adequate treatment with clozapine. The impact of clozapine-resistant schizophrenia (CRS) is even greater than that of treatment resistance in terms of severe and persistent symptoms, relapses and hospitaliza...

Descripción completa

Detalles Bibliográficos
Autor principal: Chakrabarti, Subho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394694/
https://www.ncbi.nlm.nih.gov/pubmed/34513606
http://dx.doi.org/10.5498/wjp.v11.i8.429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394694/
https://www.ncbi.nlm.nih.gov/pubmed/34513606
http://dx.doi.org/10.5498/wjp.v11.i8.429

Ejemplares similares